http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Affichage des articles dont le libellé est Novartis: Lymphoma study shows CART on track for 2017 U.S. submission. Afficher tous les articles
Affichage des articles dont le libellé est Novartis: Lymphoma study shows CART on track for 2017 U.S. submission. Afficher tous les articles
dimanche 6 décembre 2015
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
ZURICH (Reuters) - Swiss drugmaker Novartis said the latest findings from a study on its newest therapy for two kinds of blood cancer track earlier results, bolstering its confidence in a 2017 U.S. regulatory submission.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Inscription à :
Articles (Atom)